MedTrace Logo

Effect of Vitamin Supplementation in Glaucoma Patients

NCT05080153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2021-10-15

No results posted yet for this study

Summary

The impact of targeted vitamin supplementation on retinal venous pressure (RVP) and steady state pattern ERG (SSpERG) in patients with RVP 15mmHg or more above intra-ocular pressure (IOP) and serum homocystein 12µmol/l or more, with signs of progression in spite of adequate IOP control, as evidenced by SSpERG abnormality with or without structural progression or visual field progression,

Conditions

  • Glaucoma
  • Homocysteinemia
  • Elevated Retinal Venous Pressure
  • Abnormal Steady State Pattern Electroretinography

Interventions

DIETARY_SUPPLEMENT

Ocufolin forte

start of ocufolin forte 1 dd after RVP measurement, till 90 tablets are finished (3 months)

Sponsors & Collaborators

  • Devogelaere Vision

    lead OTHER

Principal Investigators

  • Thibaut Devogelaere, MD, FEBO · Vision Devogelaere

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2020-10-31
Completion
2021-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080153 on ClinicalTrials.gov